Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ8558570,23
KB874,58750,34
PKN68,3268,370,90
Msft1,65
Nokia3,4353,440,61
IBM0,16
Mercedes-Benz Group AG73,8673,9-0,23
PFE0,23
24.04.2024 9:18:00
Indexy online
AD Index online
select
AD Index online
 

  • 24.04.2024 9:12:04
Coloplast -B- (Copenhagen)
Poslední obchod Změna (%) Změna (DKK) Objem obchodů (DKK)
924,60 0,87 8,00 3 547 690
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 24.04.2024
Popis společnosti
Obecné informace
Název společnostiColoplast A/S
TickerCOLO B
Kmenové akcie:Ordinary Shares Class B
Kmenové akcie:Ordinary Shares
RICCOLOb.CO
ISINDK0060448595
Poslední známé roční výsledky30.09.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 31.12.2023 15 751
Akcie v oběhu k 31.12.2023 224 824 825
MěnaDKK
Kontaktní informace
UliceHoltedam 1-3
MěstoHUMLEBAEK
PSČ3050
ZeměDenmark
Kontatní osobaAleksandra Dimovska
Funkce kontaktní osobySenior Director, Investor Relations
Telefon4 549 111 111
Fax4549111555
Kontatní telefon4 549 112 458

Business Summary: Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The Company supplies products to hospitals, institutions as well as wholesalers and pharmacies.
Financial Summary: BRIEF: For the three months ended 31 December 2023, Coloplast A/S revenues increased 8% to DKR6.61B. Net income increased 8% to DKR1.21B. Revenues reflect Chronic Care segment increase of 4% to DKR4.45B, Wound & Skin Care segment increase of 6% to DKR717M, Voice & Respiratory Care segment increase of 6% to DKR508M, Other Developed Markets segment increase of 18% to DKR1.93B, European Markets segment increase of 4% to DKR3.57B.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Supplies
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical Appliance and Supplies Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
NAICS2007Surgical Appliance & Supplies Mfg
NAICS2007Surgical & Medical Instrument Mfg
NAICS1997Surgical Appliance and Supplies Manufacturing
NAICS1997Surgical and Medical Instrument Manufacturing
SICSurgical Appliances And Supplies
SICSurgical And Medical Instruments



  • Poslední aktualizace: 24.04.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board of DirectorsLars Rasmussen6405.12.2018
President, Chief Executive Officer, Member of the Executive ManagementKristian Villumsen5404.12.2018
Deputy Chairman of the BoardNiels Louis-Hansen76
Chief Financial Officer, Executive Vice President, Member of the Executive ManagementAnders Lonning-Skovgaard4901.07.2014
Executive Vice President - Innovation, Member of the Executive ManagementNicolai Andersen-01.10.2020
Executive Vice President - Growth, Member of the Executive ManagementPaul Marcun5501.01.2015
Executive Vice President - Global Operations, Member of the Executive ManagementAllan Rasmussen5401.07.2014
Senior Vice President, People and CultureDorthe Ronnau-01.01.2022